Better Adherence With New Oral Anticoagulant in Atrial Fibrillation : Effectiveness of a Personalized Education Program

NCT02422602 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

196

Enrollment

OTHER

Sponsor class

Conditions

Non-valvular Atrial Fibrillation

Interventions

DRUG: Xarelto
OTHER: Experimental: Personalized information intervention

Sponsor

University Hospital, Montpellier